Development and psychometric properties of the Suicidality: Treatment Occurring in Paediatrics (STOP) Suicidality Assessment Scale (STOP-SAS) in children and adolescents

BMC Pediatrics

Research Article

D. Purper-Ouakil¹  R. Frongia²  A. Zuddas²  I. Méndez³  I. Flamarique⁴  J. Castro-Fornieles⁵  C. Llorente⁶  C. Arango⁶  R. Sala⁷  K. Lievesley⁷  F. Fiori⁷  P. Santosh⁸  U. Schulze⁹  J. K. Buitelaar^1,10  P. J. Hoekstra^1,11  R. W. Dittmann^1,12  D. Coghill^1,13 

[1] CHRU Montpellier, Hôpital Saint Eloi, Médecine Psychologique de l’Enfant et de l’Adolescent, Montpellier, France;INSERM U894-Team 1. Center of Psychiatry and Neurosciences, Paris, France;Department of Biomedical Sciences, Cagliari University Hospital, University of Cagliari, Cagliari, Italy;Department of Child and Adolescent Psychiatry and Psychology, SGR1119, Institut Clinic de Neurociències, Hospital Clínic Universitari of Barcelona, Fundació Clínic per la Recerca Biomèdica, C/Villarroel, 170, 08036, Barcelona, Spain;Department of Child and Adolescent Psychiatry and Psychology, SGR1119, Institut Clinic de Neurociències, Hospital Clínic Universitari of Barcelona, Fundació Clínic per la Recerca Biomèdica, C/Villarroel, 170, 08036, Barcelona, Spain;Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Madrid, Spain;Department of Child and Adolescent Psychiatry and Psychology, SGR1119, Institut Clinic de Neurociències, Hospital Clínic Universitari of Barcelona, Fundació Clínic per la Recerca Biomèdica, C/Villarroel, 170, 08036, Barcelona, Spain;Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Madrid, Spain;Department of Psychiatry and Clinical Psychology, University of Barcelona, Barcelona, Spain;Institut d’Investigació Biomèdica August Pi i Sunyer, IDIBAPS, Barcelona, Spain;Department of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañón, CIBERSAM, IiSGM, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain;Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King’s College London, London, UK;Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King’s College London, London, UK;Centre for Interventional Paediatric Psychopharmacology, South London and Maudsley NHS Foundation Trust, London, UK;Department of Child and Adolescent Psychiatry/Psychotherapy, University of Ulm, Ulm, Germany;Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Centre, and Karakter Child and Adolescent Psychiatry University Centre, Nijmegen, The Netherlands;Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands;Paediatric Psychopharmacology, Department of Child and Adolescent Psychiatry, Central Institute of Mental Health (CIMH), Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany;University of Dundee, Dundee, UK;

关键词: Suicidality;    Adverse events;    Adolescents;    Children;    Parents;    Assessment;    Scale;   

DOI  :  10.1186/s12887-016-0751-2

 received in 2015-09-19, accepted in 2016-12-02,  发布年份 2016

来源: Springer

【 摘 要 】

BackgroundTo create a self-reported, internet-based questionnaire for the assessment of suicide risk in children and adolescents.MethodsAs part of the EU project ‘Suicidality: Treatment Occurring in Paediatrics’ (STOP project), we developed web-based Patient Reported Outcome Measures (PROMs) for children and adolescents and for proxy reports by parents and clinicians in order to assess suicidality. Based on a literature review, expert panels and focus groups of patients, we developed the items of the STOP Suicidality Assessment Scale (STOP-SAS) in Spanish and English, translated it into four more languages, and optimized it for web-based presentation using the HealthTrackerTM platform. Of the total 19 questions developed for the STOP-SAS, four questions that assess low-level suicidality were identified as screening questions (three of them for use with children, and all four for use with adolescents, parents and clinicians). A total of 395 adolescents, 110 children, 637 parents and 716 clinicians completed the questionnaire using the HealthTrackerTM, allowing us to evaluate the internal consistency and convergent validity of the STOP-SAS with the clinician-rated Columbia Suicide Severity Rating Scale (C-SSRS). Validity was also assessed with the receiver operating characteristic (ROC) area of the STOP-SAS with the C-SSRS.ResultsThe STOP-SAS comprises 19 items in its adolescent, parent, and clinician versions, and 14 items in its children’s version. Good internal consistency was found for adolescents (Cronbach’s alpha: 0.965), children (Cronbach’s alpha: 0.922), parents (Cronbach’s alpha: 0.951) and clinicians (Cronbach’s alpha: 0.955) versions. A strong correlation was found between the STOP-SAS and the C-SSRS for adolescents (r:0.670), parents (r:0.548), clinicians (r:0.863) and children (r:0.654). The ROC area was good for clinicians’ (0.917), adolescents’ (0.834) and parents’ (0.756) versions but only fair (0.683) for children’s version.ConclusionsThe STOP-SAS is a comprehensive, web-based PROM developed on the HealthTrackerTM platform, and co-designed for use by adolescents, children, parents and clinicians. It allows the evaluation of aspects of suicidality and shows good reliability and validity.

【 授权许可】

CC BY   
© The Author(s). 2016